Head to head
Transcat vs Cintas
Side-by-side on the measures that matter, with a plain-English read. Full detail: TRNS · CTAS
TRNS
Transcat
92.97-4.68%
1-year price shape — +73% over the period
Quant Rating C · 94/100
vs
CTAS
Cintas
220.01+0.50%
1-year price shape — +21% over the period
Quant Rating C · 66/100
1-year performance, rebased to 100
Cintas edges it on the scoreable measures. Cintas trades cheapest on trailing earnings; Cintas pays the highest dividend yield; Cintas earns the most per share.
| TRNS | CTAS | |
|---|---|---|
| Snapshot | ||
| Sector | Specialty Business Services | Specialty Business Services |
| Last price | 92.97 | 220.01 |
| Change today | -4.68% | +0.50% |
| 1-year return | +72.9% | +21.0% |
| Market cap | $874.37M | $87.36B |
| 52-week range | 50.23 – 112.44 | 159.94 – 232.93 |
| Valuation | ||
| P/E (TTM) | 189.73 | 43.39 |
| P/E percentile, own 5-yr range | 95th | 65th |
| P/B | 2.83 | 16.79 |
| Dividend yield | 0.00% | 0.85% |
| Profitability & growth | ||
| EPS (TTM) | 0.57 | 4.91 |
| Net profit (TTM) | $5.36M | $1.95B |
| Revenue (TTM) | $363.22M | $11.56B |
| Provider revenue period date | 2026-09-25 | 2026-08-30 |
| Revenue growth (YoY) | +18.0% | +10.9% |
| Gross margin | 32.8% | 51.0% |
| Operating margin | 3.6% | 23.6% |
| Net margin | 1.3% | 17.8% |
| Free cash flow (TTM) | $22.97M | $2.03B |
| Provider cash-flow period date | 2026-09-25 | 2026-08-30 |
| Ownership & sentiment | ||
| Institutional ownership | 94.1% | 69.3% |
| Insider activity (12mo) | 37 buy / 13 sell | 41 buy / 9 sell |
| Short interest (% of float) | 4.0% | 2.6% |
| Analyst consensus | 100% buy (5) | 64% buy / 29% hold / 7% sell (14) |
| Analyst price target | $111 (+19%) | $225 (+2%) |
| StockVane view | ||
| StockVane Quant Rating | C (94) | C (66) |
| Company | ||
| Employees | 1,413 | 48,100 |
| Founded | 1964 | 1968 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.